Wearable Sensor Monitoring for Frontotemporal Dementia
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study tests a wearable sensor device that remotely tracks physical activity and movement patterns in people with frontotemporal dementia (a type of brain condition affecting thinking and behavior). The goal is to see if this technology can help doctors monitor disease progression and catch changes early without frequent clinic visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 40 or older with a clinical diagnosis of possible or probable frontotemporal dementia (a progressive brain condition)
- Fluent in English, able to read and speak it comfortably
- Able to understand the study and give informed consent
- Have a caregiver or study partner willing to help with all study activities
- No other serious neurological, medical, or psychiatric conditions that would interfere with the study
- No history of frequent falls (more than 5 per month)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from people with neurodegenerative diseases, some family members, and healthy controls to help researchers better understand these conditions. It may help future diagnosis and research, and participation may include noninvasive checks and other procedures depending on your situation.
This study uses smart devices to measure how FTD affects movement and speech. It aims to find better ways to track the disease over time.
This study follows people with frontotemporal dementia (FTLD) and related conditions, and collects health and (for some people) body fluid information, to understand how these illnesses change over time. It may help researchers track disease signs and find better ways to measure progression.
This study tests a non-invasive brain stimulation technique called tACS (transcranial alternating current stimulation) in people with frontotemporal dementia. The goal is to see if it can improve symptoms like behavior and language problems.
This study looks at complex brain and body changes in people with ALS and frontotemporal dementia (FTD), or related disorders. If you have one of these diagnoses—or a known gene mutation that can cause ALS/FTD—you may be able to help researchers learn how the conditions progress.
This study tests a wearable sensor device that tracks walking and thinking to help detect and monitor early memory decline. Participation involves wearing the sensor during daily activities and attending clinic visits, which may help identify changes in cognitive function over time.
Hear when a new Frontotemporal Lobar Degeneration (FTLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.